Karl,
***News************
biz.yahoo.com
Monday May 4, 2:35 pm Eastern Time
Company Press Release
SOURCE: SafeScience, Inc.
SafeScience To Begin Trading On Nasdaq
BOSTON, May 4 /PRNewswire/ -- SafeScience, Inc., (Nasdaq: SAFS - news) today announced that its Common Stock will begin trading on the Nasdaq Small Cap Market under its current ticker symbol SAFS beginning Monday, May 4, 1998.
''We are pleased that we are able to join this prestigious stock exchange,'' said Bradley Carver, President, SafeScience, Inc. ''With this move to Nasdaq, the SafeScience(R) brand of products will gain increased exposure to a larger community of investors who can share in our Company's mission.''
The news today comes after several exciting announcements made within the past six months. In January, SafeScience announced a name change to more accurately reflect the Company's goal of developing and marketing products that embody the concept of 'responsible science.' The Company has also announced EPA approval to market its lead agricultural compound, a plant defense booster, Greenleaf(TM), for the prevention of crop fungus, the signing of distribution agreements with companies in Australia, New Zealand, United Arab Emirates and Saudi Arabia, and an exclusive worldwide partnership with Dominion BioSciences to develop and market its non-toxic consumer pest control products under the SafeScience(R) brand.
SafeScience also recently announced that a prestigious research institute in Israel, MIGAL Galilee Technology Center, has adopted the SafeScience(R) name. This is the first of several research partnerships with the academic community planned by the Company to increase the technology base for building the SafeScience(R) world brand.
In addition to increased market visibility, the move to Nasdaq will provide brokers and SafeScience shareholders with the most immediate access to pricing information. NASDAQ, the fastest growing stock market in the world, also offers SafeScience the advantage of multiple market makers that will compete for the best bid and ask prices.
SafeScience, Inc., (formerly IGG International, Inc.) is developing and in-licensing a portfolio of efficacious agricultural and pharmaceutical products to be marketed under the brand 'SafeScience(R)' as an alternative to conventional products employing potentially harmful chemicals. Beyond the Company's agricultural products, its human therapeutic products include a carbohydrate compound to treat cancer, which is in human clinical trials, as well as an antifungal compound. Further information is available on SafeScience's web site: safesci.com.
SafeScience Safeharbor Statement
Any statements contained in this release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including, but not limited to, risks of product nonapproval or product development and market acceptance risks, the impact of competitive products and pricing, the results of current and future licensing and other collaborative relationships, the results of financing efforts, developments regarding intellectual property rights and litigation, and other risks identified in the Company's Securities and Exchange Commission filings. Actual results, events or performance may differ materially. Readers are cautioned not to place undo reliance on these forward-looking statements, which speak only as the date hereof. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
SOURCE: SafeScience, Inc.
-------------------------------------------------------------------------------- |
